Articles From: Globo Receives FIPS 140-2 Certification for its GO!Enterprise Product Portfolio to GM ignition switch death toll grows to 32 people


Globo Plc (LSE-AIM: GBO), the international provider of enterprise mobility management (EMM) solutions and software as a service (SaaS), is pleased to announce that the National Institute of Standards and Technology (NIST) Cryptographic Module Validation Program (CMVP) has validated Globo’s cryptographic modules as per Federal Information Processing Standards (FIPS) 140-2 Security Standard for Cryptographic Modules.
Sign-up for Globo Receives FIPS 140-2 Certification for its GO!Enterprise Product Portfolio investment picks
http://media.marketwire.com/attachments/200707/352896_CapitalLink.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167489&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Globus Maritime Limited CEO Discusses Latest Company Developments and Future Plans investment picks
http://media.marketwire.com/attachments/201103/22962_GLOBUS_logonew.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163368&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for Globus Maritime Limited Reports Financial Results for the Quarter and Nine Month Period Ended September 30, 2014 investment picks
http://media.marketwire.com/attachments/201103/22962_GLOBUS_logonew.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162910&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for Globus Maritime Sets Date for the Release of Third Quarter and Nine Months 2014 Results, Conference Call and Webcast investment picks
Globus Medical , Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Sign-up for Globus Medical Announces Acquisition of Transplant Technologies of Texas investment picks
Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, and the worldwide leader in expandable interbody technology, today announced the launch of ALTERA™, the first new minimally invasive fully articulating expandable spacer for spinal fusion.
Sign-up for Globus Medical Announces ALTERA™ Minimally Invasive Articulating Expandable Spacer investment picks
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2014.
Sign-up for Globus Medical Reports 2014 Third Quarter Results investment picks
Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the year ending December 31, 2014, in advance of its annual national sales meeting being held later this week.
Sign-up for Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results investment picks
HOUSTON, Oct.
Sign-up for Glori Energy Inc. Extends Technology Partnership With Statoil investment picks
-- Progress on AERO deployment in Coke Field continues --
Sign-up for Glori Energy Provides Operations Update investment picks
Total Revenues up 604% Year over Year AERO Service Revenues up 129% Year over Year Oil Production increased 10% from 2 nd Quarter 2014 Key AERO Technology Patent Awarded HOUSTON, Nov.
Sign-up for Glori Energy Reports Third Quarter 2014 Operating and Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979877001&sourceType=1 http://media3.marketwire.com/logos/20141117-BBTH%20Logo%20200.jpg HOLLYWOOD, CALIFORNIA --
Sign-up for GloZell Headlines bBooth Opening at Westfield's Culver City Mall investment picks
Glu Mobile Inc. (NASDAQ: GLUU), a leading global developer and publisher of free-to-play games for smartphone and tablet devices, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2014 after the U.S. markets close on Wednesday, February 4, 2015.
Sign-up for Glu Announces Date of Fourth Quarter and Full Year 2014 Financial Results Release, Conference Call, and Webcast investment picks
Glu Mobile Inc. (NASDAQ:GLUU), a leading global developer and publisher of free-to-play games for smartphone and tablet devices, today announced financial results for its third quarter ended September 30, 2014.
Sign-up for Glu Reports Record Third Quarter 2014 Financial Results investment picks
2015/1/14
Gluskin Sheff + Associates Inc. Announces December 31, 2014 Assets Under Management and Performance Fees Canada NewsWire TORONTO , Jan.
Sign-up for Gluskin Sheff + Associates Inc. Announces December 31, 2014 Assets Under Management and Performance Fees investment picks
2015/1/7
Gluskin Sheff + Associates Inc. Second Quarter Fiscal 2015 Results and Conference Call Schedule Canada NewsWire TORONTO , Jan.
Sign-up for Gluskin Sheff + Associates Inc. Second Quarter Fiscal 2015 Results and Conference Call Schedule investment picks
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that healthy volunteers in a Phase 1 clinical study of GMI-1271 tolerated the drug candidate well, and that the pharmacokinetics for the drug candidate were as predicted based on preclinical data.
Sign-up for GlycoMimetics Announces Positive Top-Line Results from Phase 1 Study of GMI-1271 in Healthy Volunteers investment picks
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that data from two drug candidates in its clinical pipeline, GMI-1271 and rivipansel (formerly known as GMI-1070), will be featured during four oral presentations and two poster sessions at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition.
Sign-up for GlycoMimetics E-selectin and Sickle Cell Data to Be Highlighted at 56th ASH Annual Meeting investment picks
GlycoMimetics, Inc. (NASDAQ:GLYC) today announced that data from research related to the company’s E-Selectin antagonist (GMI-1271), focusing on its potential in treating blood cancers and coagulation disorders, were highlighted this week through four oral presentations and one poster session at the 2014 American Society of Hematology Annual Meeting in San Francisco.
Sign-up for GlycoMimetics Highlights Potential Therapeutic Benefits of Its Novel E-Selectin Antagonist at 56th ASH Annual Meeting investment picks
GlycoMimetics, Inc. (NASDAQ: GLYC) today reported financial results for the third quarter ended September 30, 2014.
Sign-up for GlycoMimetics Reports Third Quarter 2014 Results investment picks
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that Chief Financial Officer Brian Hahn will provide a company overview at the Stifel Healthcare Conference 2014 on Tuesday, November 18, 2014 at 3:00 p.m. Eastern Time.
Sign-up for GlycoMimetics to Present at Stifel Healthcare Conference 2014 investment picks
2015/1/8
By Jeff Bennett General Motors Co.
Sign-up for GM CEO: 2015 US Light-Vehicle Industry Sales Seen Between 16.5 Million-17 Million investment picks
2015/1/8
By Jeff Bennett General Motors Co.
Sign-up for GM Chief: U.S. Auto Industry Could Grow 3% in 2015 --Update investment picks
2014/11/24
By Jeff BennettTexas woman later pleaded guilty to criminal negligent homicide In her fiancé's death General Motors Co.
Sign-up for GM confirms Texas accident linked to faulty ignition switch investment picks
2015/1/21
By Peg Brickley A federal appeals court in New York on Wednesday said a paperwork mistake rendered a $1.5 billion bank loan made years ago to struggling General Motors Co.
Sign-up for GM Creditors Win Challenge to $1.5 Billion Loan -- Update investment picks
2015/1/21
DETROIT , Jan.
Sign-up for GM Declares Dividend on Common Stock investment picks
DETROIT , Jan.
Sign-up for GM Expects Improved Profitability in 2015 investment picks
2014/11/10
By Jeff Bennett The General Motors Co.
Sign-up for GM ignition switch death toll grows to 32 people investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Globo Receives FIPS 140-2 Certification for its GO!Enterprise Product Portfolio to GM ignition switch death toll grows to 32 people
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent